World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02375919
Date of registration: 24/02/2015
Prospective Registration: Yes
Primary sponsor: Assistance Publique - Hôpitaux de Paris
Public title: PERC Rule to Exclude Pulmonary Embolism in the Emergency Deparment PROPER
Scientific title: The Pulmonary Embolism Rule Out Criteria (PERC) Rule to Exclude the Diagnosis of Pulmonary Embolism in Emergency Low Risk Patients: a Non-inferiority Randomized Controlled Trial
Date of first enrolment: August 2015
Target sample size: 1922
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02375919
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Yonathan Freund
Address: 
Telephone:
Email:
Affiliation:  Assistance Publique - Hôpitaux de Paris
Key inclusion & exclusion criteria

Inclusion Criteria:

- Acute onset of, or worsening of dyspnea Or chest pain

- Low clinical pretest probability of PE, empiricially estimated by the gestalt.

Exclusion Criteria:

- Other obvious cause than PE for dyspnea or chest pain

- Acute severe presentation

- Contra-indication to CTPA

- Concurrent anticoagulation treatment

- Current diagnosed thrombo-embolic event

- Inability to follow up

- Prisoners

- Pregnancy

- No social security

- Participation in another intervention trial



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Emergency Patients
Intervention(s)
Other: PERC based Strategy
Primary Outcome(s)
Failure percentage of the diagnostic strategy (diagnosed deep venous thrombosis or pulmonary embolism) at 3 month follow up [Time Frame: 3 months]
Secondary Outcome(s)
All causes re hospitalization at 3 months [Time Frame: 3 months]
Anticoagulation therapy administration (number of day with treatment within three months) [Time Frame: 3 months]
Rate of Computed Tomography Pulmonary Angiogram (CTPA) and related adverse event [Time Frame: 3 months]
Length of stay in the Emergency Department [Time Frame: From date of entry in the emergency department to date of exit]
Rate of patients admitted in the hospital following Emergency Department visit [Time Frame: 3 months]
Death from all causes at 3 months [Time Frame: 3 months]
Secondary ID(s)
P1409
IDRCB 2015-A00215-44
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history